It's resveratrol with two atoms swapped. The change is real: most oral resveratrol is destroyed in the gut and liver before it reaches your blood, and this version survives at roughly four times the rate, though that figure comes from rats, not people 1. Once inside, it flips the same switches resveratrol does, the fuel-and-stress sensors that put cells into repair mode 2. The mechanism is plausible. Whether any of it becomes something a person feels is the open question.
The human evidence is thin, and what exists cuts the wrong way. Eighty adults with high cholesterol took placebo or pterostilbene for six to eight weeks. The high-dose group's blood pressure fell about 8 points systolic, roughly a mild blood-pressure drug. In those same people LDL cholesterol rose 17 mg/dL. People already on a statin were spared the rise 3. The cleanest functional test stacked it with a NAD+ precursor in adults aged 55 to 80, the exact group the marketing targets. Blood levels of the target molecule shot up and held. Muscle strength, soreness, stem cells, tissue: no difference on any of them 4. The brain and longevity claims trace to aged rats, with no human trial published 5.
Before you buy, this is the one decision to make.
What a year of it buys you. Six months in, the version who took it and the version who skipped look the same. A year out, the taker may carry a slightly worse lipid panel and is out $30 to $500; the skipper has that money and one fewer bottle on the shelf. The longevity payoff that anchors the sales pages has not shown up in a single human trial, so on present evidence neither person's aging trajectory bends 4.
The fine print β when to skip it, and what people get wrong
"Better resveratrol" is two claims pretending to be one. Better absorption is real, but higher blood levels only set up a benefit; they aren't one on their own, and resveratrol's own human aging trials came back null 1.
The one flagged harm is the LDL rise. Get a lipid panel before and after; if it climbs, stop 3. Untested in pregnancy and breastfeeding, so skip it there.
- 1Kapetanovic IM, Muzzio M, Huang Z, Thompson TN, McCormick DL (2011). Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemotherapy and Pharmacology. link
- 2McCormack D, McFadden D (2013). A review of pterostilbene antioxidant activity and disease modification. Oxidative Medicine and Cellular Longevity. link
- 3Riche DM, McEwen CL, Riche KD, Sherman JJ, Wofford MR, Deschamp D, Griswold M (2014). Analysis of safety from a human clinical trial with pterostilbene on metabolic parameters: a randomized, double-blind, and placebo-controlled trial. Evidence-Based Complementary and Alternative Medicine. link
- 4Jensen JB, Dollerup OL, MΓΈller AB, et al. (2022). A randomized placebo-controlled trial of nicotinamide riboside and pterostilbene supplementation in experimental muscle injury in elderly individuals. JCI Insight. link
- 5Dutta BJ, Rakshe PS, Maurya N, Chib S, Singh S (2023). Unlocking the therapeutic potential of natural stilbene: Exploring pterostilbene as a powerful ally against aging and cognitive decline. Ageing Research Reviews. link
- 6Riche DM, McEwen CL, Riche KD, Sherman JJ, Wofford MR, Deschamp D, Griswold M (2013). Analysis of safety from a human clinical trial with pterostilbene. Journal of Toxicology. link
Pterostilbene
Cheap as a bare capsule (about $20-40 a year). Branded longevity stacks that include it push $300 and up.
One pill a day with a meal that has some fat in it.
One small human trial with mixed results β blood pressure down, LDL cholesterol up. The cleanest functional follow-up was negative. The longevity claims are extrapolated from animals.
Plausible cellular-aging mechanism, but no human trial has measured any aging-trajectory or skin endpoint β and the LDL signal works against long-term vascular health.
A real blood-pressure drop at the high dose, but the same trial saw LDL cholesterol rise β short-term wellness is a wash at best.
A plausible longevity molecule on paper. Zero human trials have shown a longevity benefit, and the one functional test in older adults came back negative.